Abbott Laboratories buy Piper Jaffray Companies
Start price
19.09.24
/
50%
€103.70
Target price
19.09.25
€117.65
Performance (%)
12.09%
End price
20.09.25
€116.24
Summary
This prediction ended on 20.09.25 with a price of €116.24. The BUY prediction by Piper_Jaffray_Compan finished with a performance of 12.09%. Dividends of €1.08 are taken into consideration when calculating the performance. Piper_Jaffray_Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Abbott Laboratories | -2.451% | -2.451% | -3.701% |
| iShares Core DAX® | 1.644% | 4.865% | 25.089% |
| iShares Nasdaq 100 | 0.747% | 2.923% | 8.975% |
| iShares Nikkei 225® | 2.442% | 6.212% | 21.408% |
| iShares S&P 500 | 0.618% | 2.843% | 5.726% |
Comments by Piper_Jaffray_Compan for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE: ABT) is now covered by analysts at Piper Sandler Companies. They set an "overweight" rating and a $131.00 price target on the stock.
Ratings data for ABT provided by MarketBeat
In the thread Trading Abbott Laboratories
Die von Piper_Jaffray_Compan gewählte maximale Laufzeit wurde überschritten